Tagged Articles

adverse reactions 92 articles

Man suffers paranoid psychosis, cognitive impairment after taking Hepatitis C treatment

A frightening new side effect has emerged with the standard treatment for the hepatitis C – paranoid psychosis and cognitive impairment, according to a report published in a recent issue of General Hospital Psychiatry. According to the report, a 55-yearold male was diagnosed with paranoid psychosis and cognitive impairment after being treated for four months with interferon-based hepatitis C virus antiviral therapy. The psychosis stopped after he continued the therapy and he began treatment with the antipsychotic medication risperidone (Risperdal), however the cognitive impairment could not be reversed. Months later when doctors attempted to lower his dosage of risperidone, the paranoid ... Read More

Healthier diabetics may fare better with less aggressive approach to disease management

Type 2 diabetes drugs could be doing patients more harm than good, especially older diabetics, a new study shows. The research, published in a recent edition of the Journal of the American Medical Association Internal Medicine, addressed how current guidelines for diabetes management were serving patients. Currently, diabetes management involves intensifying treatment until the patient’s blood sugar level has evened out. Researchers say this method appears to cause more negative impacts to patients than positive ones. “For people with type 2 diabetes, the goal of managing blood sugar levels is to prevent associated diabetes complications, such as kidney, eye and ... Read More

Vials of blood thinner Coumadin recalled due to possible contamination

Six lots of the commonly prescribed blood thinner Coumadin (warfarin) are being recalled because visible particulate matter was found in some vials of the drug. If injected, particulate – whether of metallic or non-metallic cellulose matter – can cause serious and potentially fatal adverse reactions including embolization, as well as allergic reactions. Coumadin is a prescription medication used to treat blood clots and to lower the risk of blood clots forming in the body. It is available in both an oral and an injectable formulation. The injectable formulation is typically administered in a hospital setting by health care professionals to ... Read More

Drug companies plan to market OTC version of ED drug Cialis

Drug companies are devising a plan to market a nonprescription version of the erectile dysfunction drug Cialis (tadalafil) in major markets, however they will have an uphill battle with regulators to get the impotence drugs on store shelves. Drug makers Eli Lilly & Co. and Sanofi SA have struck a licensing deal to sell the blockbuster prescription drug as an over-the-counter product. Cialis generated as much as $2.2 billion in sales last year, overtaking its rival Viagra, which drummed up $1.9 billion in revenue last year. The drug makers are targeting the United States, Canada and Australia for exclusive rights ... Read More

FDA approves new ‘high-intensity’ sugar substitute

A new zero-calorie sweetener will soon hit store shelves, giving consumers more sugar substitute options to sweeten or add flavor to their foods, the Food and Drug Administration (FDA) announced. The new sweetener is called advatame, but does not yet have an official brand name. Advatame, along with other marketed sugar substitutes, are called high-intensity sweeteners “because small amounts pack a large punch when it comes to sweetness,” says Captain Andrew Zajac, U.S. Public Health Service (USPHS) director of the Division of Petition Review at the Food and Drug Administration (FDA). Unlike sweeteners like sugar, honey or molasses, high-intensity sweeteners ... Read More

Fresenius issues second recall of NaturaLyte due to bacterial contamination

Fresenius Medical Care, the world’s largest provider of dialysis products and services, is recalling 56 lots of NaturaLyte Liquid Bicarbonate Concentrate, which is used in hemodialysis machines, because the dialysis concentrate may be contaminated with bacteria, which could lead to bacteremia or systemic infection in patients treated with affect products. Fresenius says that the dialysis filter, called a dialyzer, and the use of the Diasafe filter or equivalent create an effective bacteria and endotoxin barrier that reduces the likelihood of adverse events from occurring. The announcement follows a recall of 49 lots of NaturaLyte due to high levels of bacterial contamination ... Read More

FDA adds new adverse events to label of antipsychotic drug Risperdal

Safety labels for the antipsychotic drug Risperdal, or risperidone, have been updated to include a new Adverse Reactions involving rare anaphylactic reactions in patients after receiving an injection of the drugs in patients who have previously tolerated the oral version of the drug. The new label will go into effect immediately, the Food and Drug Administration (FDA) announced. Risperdal is approved to treat bipolar disorder, schizophrenia and irritability with autism in adults and children. It is sometimes prescribed off label to treat conditions such as attention-deficit hyperactivity disorder (ADHD), attention-deficit disorder (ADD), and other behavior problems. Risperdal side effects are ... Read More

European Union approves new combination treatment for type 2 diabetes

European Union drug regulators have approved a new combination pill to treat type 2 diabetes. Vokanamet combines the new diabetes drug Invokana with the standard treatment metformin. The new treatment is made by Johnson & Johnson and will be marketed in Europe by Janssen-Cliag International. The active ingredient in Invokana is canagliflozin, which is in a class of diabetes medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. These drugs are designed to help reduce blood sugar levels by preventing the reabsorption of glucose from the kidneys back into the blood, and allows glucose to be excreted in the urine. The U.S. ... Read More

Homeopathic treatments recalled; potential for serious allergic reactions

Several lines of homeopathic treatments made by Terra-Medica are being recalled because they may contain penicillin or derivatives of the antibiotic, which could cause allergic reactions in some people. The recall includes 56 lots of Pleo-FORT, Pleo-QUENT, Pleo-NOT, Pleo-STOLO, Pleo-NOTA-QUENT, and Pleo-EX homeopathic treatments in liquid, tablet, capsule, ointment, and suppository forms. The products are used to treat a variety of ailments from digestion problems, colds and sinus problems, viruses, and yeast infections. The Food and Drug Administration (FDA) has determined that these products produce penicillin or derivatives of penicillin during the fermentation process. Exposure to penicillin in patients who ... Read More

New diabetes drug gets positive review from European drug advisors

An advisory committee for the European drug authority is recommending the approval of empagliflozin, a new type 2 diabetes drug made by Boehringer Ingelheim and Eli Lilly and Company. Empagliflozin is in a new class of diabetes drugs known as sodium glucose co-transporter 2, or SGLT-2, inhibitors. It works by targeting glucose directly and works independently of B-cell function and insulin resistance. The drug produces increased urinary glucose excretion, with a consequent lowering of plasma, glucose levels, and weight loss. If approved, the empagliflozin would be marketed under the name Jardiance. Earlier this month, the U.S. Food and Drug Administration ... Read More